ZYME

Zymeworks Stock Analysis

AI Rating

Good
  • Quality2/10
  • Growth↑ 7/10
  • Momentum↑ 8/10
Zymeworks sales and earnings growth
ZYME Growth
Good
  • Revenue Y/Y↑ 116.21%
  • EPS Y/Y↑ 42.95%
  • FCF Y/Y↓ -15.68%
Zymeworks gross and profit margin trends
ZYME Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -47.20%
  • ROIC↓ -19.20%
Zymeworks net debt vs free cash flow
ZYME Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Zymeworks stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗